Cardiovascular Health

This Month's Top Stories from Rheumatology Network

April 11, 2019

In this slideshow, we highlight some recent noteworthy advances in rheumatology, including new developments on the benefits of chiropractic care, how best to adopt methotrexate into a treatment plan, a possible new benefit for fatty acids, and much more.

Biologics for PsA not Associated with Higher Heart Disease Risk

April 09, 2019

Study shows there is no substantial difference in cardiovascular risk associated with different biologic therapies for psoriasis and psoriatic arthritis patients.

CV Risk in Rheumatic Disease

January 23, 2019

(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia predicts mortality.

NSAIDs: How Safe for High-Risk Patients?

December 19, 2018

Canadian researchers looked at the safety of short-term use in patients with hypertension, heart failure, or chronic kidney disease.

Gout Doubles the Risk of Atrial Fibrillation in Older Adults

August 23, 2018

Findings from one of the few studies that have looked at the risk of arrhythmias related to gout in elderly patients.

Extra-articular Manifestations of RA: A Quiz

July 17, 2018

How high is the risk of CV disease in RA? What rare but serious complications can rheumatoid vasculitis cause? Answers here.

Hot Topics in Psoriatic Arthritis: Updates From EULAR 2018

July 09, 2018

Two recent studies focus on the risks of osteoporosis and cardiovascular disease in patients on the psoriatic arthritis/psoriasis spectrum.

RA Comorbidities: A Short Quiz

May 31, 2018

Which organs are most commonly affected? What’s the impact of RA therapies on comorbidities? Answers here.

Gout and Cardiovascular Risk

April 16, 2018

Here: the latest evidence on the effects of febuxostat, allopurinol, and statins on CV mortality in patients with gout.

Risk of Cardiac Disease in Patients With Spondyloarthropathies

April 10, 2018

A study sheds new light on the extra-articular manifestations of spondyloarthritis-with a focus on the heart as a high-risk target.